image 1 image 2

Dr. Suginlal

image 3

Academic Qualification : 

M. Pharm., Ph. D

Date of Joining: 07.04.2016

Research Experience & Area of Specialisation

Seven years in Pharmaceuticals industries such as

Glenmark Research Centre,

Dr.Reddys laboratories Ltd,

Mylan  laboratories Ltd and

Suven Life Science  with

5 years in Academics  & In-vivo Pharmacology and Toxicology


Satiesh kumar R, Sugin Lal Jabaris. S, Ramesh K, Madhan B.  Effect of type 1 collagen and its hydrolysed collagen peptides on the healing of mucosal ulcers in murine model of ulcerative colitis. Eur J Pharm Sci. 2016; In Press

Akila Kesavan P, Ilaiyaraja, Sofi Beaula W, Veena Kumari V, Sugin lal J, Arunkumar C, G. Anjana G, Satish Srinivas, Anita Suresh Kumar R, Ponraju D, Ganesh V. Tumor targeting using polyamidoamine dendrimer–cisplatin nanoparticles functionalized with diglycolamic acid and herceptin. Eur. J. Pharm. Biopharm. 2015 (16), 255-263

Sugin Lal Jabaris S, Sumathy H, Girish R, Sridhar N, Sukumar M, Saravana   Babu C,   Thanikachalam S, Mohan T. Phosphodiesterase- 4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system. Brain Res. 2015; 1622, 279- 291

Sugin Lal Jabaris S, Sumathy H, Satiesh kumar R, Sridhar N, Thanikachalam S, Saravana Babu C. Eeffects of rolipram and roflumilast, phosphodiesterase 4 inhibitors, on hypertension-induced defects in memory function in rats. Eur. J. Pharmacol. 2015; 746(5), 138-147

Sugin Lal Jabaris S, Sumathy H, Sugumar M, Shiney Monica RA, Saravana Babu C, Thanikachalam S. Beneficial effects of phosphodiesterase-4 inhibitors on hypertension-induced defects in memory function in rats.  Alzheimer's & Dementia 2014; 10 (4), P469-P470

Satiesh kumar R, Sathiamurthi P, Sugin Lal Jabaris, Madhan B. Preparation and evaluation of mesalamine in situ rectal gel using collagen carrier:  A novel therapeutic approach for treating ulcerative colitis. Eur J Pharm Sci. 2012; 48 (1-2), 104-110

Ramakrishna Nirogi, Sugin Lal Jabaris, Pradeep J, Renny A, Dhanalakshmi S, Abdul Rasheed M, Praveen Kumar Royapalley Venkatesh G. Corrigendum to “Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. [Eur. J. Pharmacol. 2011, 668, 155–162. Eur. J. Pharmacol. 2011,678 (1-3), P101

Pradeep J, Dhanalakshmi S, Sugin Lal Jabaris, Rajesh Babu R, Baburao K, Sampurna Mohanty S, Vishwottam K, Nageswararao M, Ramanatha S, Ganesh B, Ishtiyaque A, Venkat Reddy M, Ram Mohan G, Faheem MA, Anil Shinde, Amol D, Rambabu N, Ramakrishna Nirogi. SUVN-G1031, a novel selective H3 receptor antagonist in animal models of cognitive deficits. Alzheimer’s & Dementia. 2011, 7(4), S796


Arumugam K, Sugin Lal Jabaris. S, Pal M. Recent Advances on Phosphodiesterase-4 inhibitors for the Treatment of Asthmatic and Chronic Obstructive Pulmonary Disease: A Review. J. Med. Chem. 2008, 51, 5471-5489

Contact Details

044 - 26214809 (ext 212)

Personal Details:



Abroad Visit:

TWO (Denmark and Belgium) .


Has received International Travel Fellowship, AAIC 2016 from Alzheimer's Association International Conference (AAIC 2016)

Had received International Travel Fellowship from Alzheimer's Association International Conference (AAIC 2014)
Received Certificate of Merit for meritorious research publications in the year of 2013, Sri Ramachandra University, Chennai


Received certificate for my commendable and committed scientific work at Centre for Toxicology and Developmental Research (CEFT), Sri Ramachandra University, towards acquiring “Good Laboratory Practice (GLP)” accreditation by National Good Laboratory Practice Compliance Monitoring Authority (NGCMA), Department of Science and Technology, Govt. of India